메뉴 건너뛰기




Volumn 19, Issue 6, 1998, Pages 575-588

Early stopping of a clinical trial when there is evidence of no treatment benefit: Protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project

Author keywords

Bayesian methods; Breast cancer; Clinical trials; Data monitoring; Stochastic curtailment; Stopping rules; Tamoxifen

Indexed keywords

ESTROGEN RECEPTOR; PLACEBO; TAMOXIFEN;

EID: 0032427758     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(98)00041-5     Document Type: Article
Times cited : (38)

References (26)
  • 1
    • 10344238569 scopus 로고    scopus 로고
    • Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors
    • 1. Fisher B, Dignam J, Bryant J, et al. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst 1996;88:1529-1542.
    • (1996) J Natl Cancer Inst , vol.88 , pp. 1529-1542
    • Fisher, B.1    Dignam, J.2    Bryant, J.3
  • 2
    • 84953030627 scopus 로고
    • Stochastically curtailed tests in long-term clinical trials
    • 2. Lan KKG, Simon R, Halperin M. Stochastically curtailed tests in long-term clinical trials. Commun Stat Sequential Anal 1991;1:207-219.
    • (1991) Commun Stat Sequential Anal , vol.1 , pp. 207-219
    • Lan, K.K.G.1    Simon, R.2    Halperin, M.3
  • 3
    • 0027980912 scopus 로고
    • Stopping when the experimental regimen does not appear to help
    • 3. Wieand S, Schroeder G, O'Fallon JR. Stopping when the experimental regimen does not appear to help. Stat Med 1994;13:1453-1458.
    • (1994) Stat Med , vol.13 , pp. 1453-1458
    • Wieand, S.1    Schroeder, G.2    O'Fallon, J.R.3
  • 5
    • 0029903614 scopus 로고    scopus 로고
    • Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer
    • 5. Swedish Breast Cancer Cooperative Group. Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. J Natl Cancer Inst 1996;88:1543-1549.
    • (1996) J Natl Cancer Inst , vol.88 , pp. 1543-1549
  • 6
    • 8044243594 scopus 로고    scopus 로고
    • Preliminary results from the Cancer Research Campaign trial evaluating tamoxifen duration in women aged fifty years or older with breast cancer
    • 6. Current Trials Working Party of the Cancer Research Campaign Breast Cancer Trials Group. Preliminary results from the Cancer Research Campaign trial evaluating tamoxifen duration in women aged fifty years or older with breast cancer. J Natl Cancer Inst 1996;88:1834-1839.
    • (1996) J Natl Cancer Inst , vol.88 , pp. 1834-1839
  • 7
    • 0024506261 scopus 로고
    • A randomized trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor positive tumors
    • 7. Fisher B, Costantino J, Redmond C, et al. A randomized trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor positive tumors. N Engl J Med 1989;320:479-484.
    • (1989) N Engl J Med , vol.320 , pp. 479-484
    • Fisher, B.1    Costantino, J.2    Redmond, C.3
  • 10
    • 0020263135 scopus 로고
    • An aid to data monitoring in long-term clinical trials
    • 10. Halperin M, Lan KKG, Ware JH, et al. An aid to data monitoring in long-term clinical trials. Controlled Clin Trials 1982;3:311-323.
    • (1982) Controlled Clin Trials , vol.3 , pp. 311-323
    • Halperin, M.1    Lan, K.K.G.2    Ware, J.H.3
  • 11
    • 33746412158 scopus 로고
    • Upper bounds for type I and type II error rates in conditional power calculations
    • 11. Davis BR, Hardy RJ. Upper bounds for type I and type II error rates in conditional power calculations. Commun Stat Theory Meth 1991;19:3571-3584.
    • (1991) Commun Stat Theory Meth , vol.19 , pp. 3571-3584
    • Davis, B.R.1    Hardy, R.J.2
  • 13
    • 84972500231 scopus 로고
    • Statistical approaches to interim monitoring of medical trials: A review and commentary
    • 13. Jennison C, Turnbull BW. Statistical approaches to interim monitoring of medical trials: a review and commentary. Stat Sci 1990;5:299-317.
    • (1990) Stat Sci , vol.5 , pp. 299-317
    • Jennison, C.1    Turnbull, B.W.2
  • 14
    • 0031032503 scopus 로고    scopus 로고
    • 0 embedded in sequential tests
    • 0 embedded in sequential tests. Stat Med 1997;16:465-477.
    • (1997) Stat Med , vol.16 , pp. 465-477
    • Betensky, R.A.1
  • 15
    • 0028146249 scopus 로고
    • The what, why and how of Bayesian clinical trials monitoring
    • 15. Freedman LS, Spiegelhalter DJ, Parmar MKB. The what, why and how of Bayesian clinical trials monitoring. Stat Med 1994;13:1371-1383.
    • (1994) Stat Med , vol.13 , pp. 1371-1383
    • Freedman, L.S.1    Spiegelhalter, D.J.2    Parmar, M.K.B.3
  • 17
    • 0030463407 scopus 로고    scopus 로고
    • Five years of tamoxifen - Or more?
    • 17. Peto R. Five years of tamoxifen - or more? J Natl Cancer Inst 1996;88:1791-1793.
    • (1996) J Natl Cancer Inst , vol.88 , pp. 1791-1793
    • Peto, R.1
  • 18
    • 0029904559 scopus 로고    scopus 로고
    • Tamoxifen: The long and short of it
    • 18. Swain SM. Tamoxifen: the long and short of it. J Natl Cancer Inst 1996;88:1510-1512.
    • (1996) J Natl Cancer Inst , vol.88 , pp. 1510-1512
    • Swain, S.M.1
  • 19
    • 0000388854 scopus 로고
    • Asymmetric group sequential boundaries for monitoring clinical trials
    • 19. DeMets DL, Ware JH. Asymmetric group sequential boundaries for monitoring clinical trials. Biometrika 1982;69:661-663.
    • (1982) Biometrika , vol.69 , pp. 661-663
    • DeMets, D.L.1    Ware, J.H.2
  • 20
    • 0002296743 scopus 로고
    • Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis
    • 20. Pampallona S, Tsiatis AA. Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis. J Stat Plan Infer 1994;42:19-35.
    • (1994) J Stat Plan Infer , vol.42 , pp. 19-35
    • Pampallona, S.1    Tsiatis, A.A.2
  • 21
    • 0020729398 scopus 로고
    • Group sequential clinical trials with triangular continuation regions
    • 21. Whitehead J, Stratton I. Group sequential clinical trials with triangular continuation regions. Biometrics 1983;39:227-236.
    • (1983) Biometrics , vol.39 , pp. 227-236
    • Whitehead, J.1    Stratton, I.2
  • 23
    • 0029834102 scopus 로고    scopus 로고
    • Assessing whether to perform a confirmatory randomized clinical trial
    • 23. Parmar MKB, Ungerleider RS, Simon R. Assessing whether to perform a confirmatory randomized clinical trial. J Natl Cancer Inst 1996;88:1645-1651.
    • (1996) J Natl Cancer Inst , vol.88 , pp. 1645-1651
    • Parmar, M.K.B.1    Ungerleider, R.S.2    Simon, R.3
  • 24
    • 0030595683 scopus 로고    scopus 로고
    • When is a confirmatory randomized clinical trial needed?
    • 24. Berry DA. When is a confirmatory randomized clinical trial needed? J Natl Cancer Inst 1996;88:1606-1607.
    • (1996) J Natl Cancer Inst , vol.88 , pp. 1606-1607
    • Berry, D.A.1
  • 25
    • 0030055509 scopus 로고    scopus 로고
    • Randomized trial of five years of adjuvant tamoxifen with continuous therapy for operable breast cancer
    • The Scottish Cancer Trials Breast Group
    • 25. Stewart HJ, Forrest AP, Everington D. Randomized trial of five years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group. Br J Cancer 1996;74:797-799.
    • (1996) Br J Cancer , vol.74 , pp. 797-799
    • Stewart, H.J.1    Forrest, A.P.2    Everington, D.3
  • 26
    • 0030479062 scopus 로고    scopus 로고
    • Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node positive breast cancer
    • 26. Tormey DC, Gray R, Falkson HC. Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node positive breast cancer. J Natl Cancer Inst 1996;88:1828-1833.
    • (1996) J Natl Cancer Inst , vol.88 , pp. 1828-1833
    • Tormey, D.C.1    Gray, R.2    Falkson, H.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.